News

Currently, the company is enrolling cancer patients in a Phase Ib clinical trial and expects to complete the trial in the first quarter of 2015. In preclinical trials,

Overall, the study demonstrated positive results with respect to the trial’s primary efficacy endpoint with no serious adverse events. Lipocine continues to expect to file a New Drug

In addition to this recently allowed application, the patent family includes applications pending in other major markets including Australia, Canada, China, Europe and Japan. The exclusively licensed technology

This grant was made by the National Institute of Environmental Health Sciences to create a novel method for extracting molecular information from archived tissues. FFPE sample archives contain

The funding is a Phase 1 award granted under the Small Business Innovation Research Funding Award Program. The purpose of this project is to determine the most useful

In the collaboration Inovio and GeneOne will co-develop Inovio’s DNA-based Ebola vaccine through a phase I clinical trial. The companies are currently conducting pre-IND activities and plan to

In October 2012, the FDA approved Minivelle for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause, also known as hot flashes. Minivelle includes bioidentical

The data submitted in the NDA includes a Japanese Phase III trial, which showed 100% SVR12 rates and patients who achieve SVR12 are cured of HCV infection. The

RDEB is the most severe form of the rare connective tissue disorder epidermolysis bullosa and it causes severe blistering and areas of missing skin that occurs when a